Pharmaceutical Cold Chain Storage: How to Safeguard Medicines in 2025
Mis à jour en novembre 26, 2025
Maintenir pharmaceutical cold chain storage is no longer a niche concern—it’s a critical safeguard for patients and supply chains. Par 2025 the global cold chain logistics market is forecast to surge from NOUS $324.85 milliards en 2024 pour nous $862.33 milliards 2032. Most vaccines and biologic medicines must be stored within 2–8 ° C, while advanced therapies may require –20 ° C, –80 °C or even –150 °C. Failure to control temperature is costly—up to 20 % of temperature sensitive drugs are compromised during transit and nearly 50 % of vaccines worldwide are wasted due to poor cold chain management. This comprehensive guide explains why the cold chain matters, how to meet strict regulations, which technologies and packaging options to consider, and what trends will shape the future of pharmaceutical storage.
Understand why cold chain storage is critical for patient safety and financial integrity.
Learn temperature requirements pour les vaccins, biologique, cell and gene therapies and other medicines.
Navigate regulatory frameworks comme le PIB, GMP and DSCSA.
Explore emerging technologies comme les capteurs IoT, Optimisation de l'itinéraire IA, blockchain and solar powered units.
Choose packaging and equipment suited to different temperature ranges.
Mettre en œuvre les meilleures pratiques for continuous monitoring, formation du personnel et planification d’urgence.
Comprendre 2025 tendances driving market growth and innovations.
Why Is Pharmaceutical Cold Chain Storage Critical?
Patient safety and product integrity: The efficacy of temperature sensitive products depends on strict storage conditions. Traditional vaccines must be kept at 2 °C à 8 °C, whereas gene therapies may need –20 °C ou moins. Even brief temperature excursions can render a vaccine or biologic ineffective because lost potency cannot be restored. Des études estiment que jusqu'à 20 % of temperature sensitive pharmaceuticals are compromised during transit, costing billions and risking patient health. Le global cold chain market for pharmaceuticals—valued around NOUS $6.4 milliards en 2024—is projected to reach NOUS $6.6 milliards en 2025 and US $9.6 milliards 2035, highlighting rapid growth and the need for resilient infrastructure.
Financial and reputational stakes: Vaccine spoilage and product recalls are expensive. Improper temperature management wastes nearly 50 % of vaccines globally. Cold chain failures cost the biopharma sector billions in lost inventory and regulatory penalties. Maintaining a dependable cold chain ensures product integrity, supports compliance and protects your organization’s reputation.
Temperature Requirements and Product Categories
Different medicines require distinct temperature ranges. Understanding these ranges helps you choose appropriate equipment, packaging and monitoring systems.
| Product category | Plage de températures typique | Pourquoi ça compte | Bénéfice pour vous |
| Vaccins standards | 2–8 ° C (36–46 °F) | La plupart des vaccins (grippe, hépatite, VPH) remain potent only within this refrigerated range. | Ensures immunity and avoids costly re vaccinations. |
| Biologique & peptides | 2–8 ° C; some require –20 °C | Anticorps monoclonaux, insuline, GLP 1 agonists and recombinant proteins degrade quickly outside controlled refrigeration. | Maintains drug efficacy and reduces patient risks. |
| Gene & thérapies cellulaires | –80 °C à –150 °C (ultra cold or cryogenic) | CAR T therapies and viral vectors require cryogenic storage; temperatures can reach –190 °C. | Preserves living cells and maximizes therapeutic success. |
| Controlled room temperature medicines | 15–25 ° C (59–77 °F) | Many oral drugs and some biologics can be stored at CRT, but still need monitoring to avoid heat or freeze damage. | Avoids product degradation and reduces energy costs. |
| Obesity medications | 2–8 ° C | GLP 1 receptor agonists (Par exemple, Wegovy, Mounjaro) require refrigeration to remain potent. | Supports growing patient demand and reduces waste. |
Conseils pratiques pour les utilisateurs
Confirm the manufacturer’s recommended range for each product; never assume one range fits all medicines.
Use purpose built medical refrigerators, not household units; dormitory style fridges may freeze vaccines even when set to 5 °C.
Avoid frequent door openings to minimise warm air entry and temperature fluctuations.
Label storage areas clearly (Par exemple, “2–8 °C medicines”) to reduce handling errors.
Document every temperature measurement—accurate records support audits and help identify patterns of deviations.
Exemple du monde réel: Pendant le déploiement du vaccin contre la COVID-19, clinics using calibrated freezers with IoT sensors maintained ultra cold temperatures for mRNA vaccines. Continuous alerts enabled staff to correct deviations quickly, reducing spoilage and ensuring uninterrupted immunization.
Which Regulations Govern Pharmaceutical Cold Chain Storage?
The pharmaceutical cold chain operates within a web of global and regional regulations. Failing to comply can lead to fines, shipment quarantines or even license suspension.
Good Distribution and Manufacturing Practice (PIB/BPF)
GDP and GMP guidelines—issued by bodies like the EMA, FDA and WHO—set standards for contrôle de la température, traceability and training. Key principles include:
Contrôle de la température: Keep medicines within specified ranges (généralement 2–8 ° C) unless otherwise indicated. Use calibrated thermometers and temperature mapping to validate storage conditions.
Matériel qualifié: Utilisation validée, regularly calibrated refrigerators, congélateurs, cold rooms and data loggers. Packaging solutions should offer adequate insulation and thermal protection.
Monitoring and documentation: Implement continuous monitoring systems with real time alerts and maintain detailed records. Blockchain technology offers tamper proof end to end traceability.
Gestion des risques: Identify potential risks (power failures, retards de transit, equipment malfunctions) et élaborer des plans d'urgence.
Formation du personnel: Former le personnel à la bonne manipulation, storage and emergency procedures.
Loi sur la sécurité de la chaîne d'approvisionnement en médicaments (DSCSA)
Aux États-Unis, le DSCSA mandates a fully electronic, interoperable tracking system by August 27 2025. After this date, wholesale distributors must exchange transaction information, verify product identifiers at the package level and report suspect medications. Le non-respect peut entraîner des amendes, shipment quarantines or license suspension. Dispensers must also electronically trace products and report suspect or illegitimate drugs, with phased deadlines extending to Novembre 2026 for small dispensers.
Other Regional Frameworks
EU Good Distribution Practice (PIB) Lignes directrices: Annex 11 of the EU’s GMP requires validated electronic systems and secure data handling.
United States Pharmacopeia (USP) <1079>: Offers guidelines for shipping temperature sensitive products.
IATA and WHO: Provide protocols for shipping with dry ice and handling vaccines.
Regulatory Table
| Règlement | Scope and key requirements | Conséquences |
| DSCSA (NOUS) | Electronic traceability, serialised product identifiers, full data exchange by August 27 2025 | Requires interoperable systems and strong data management; non compliance can halt shipments. |
| EU GDP/GMP | Validated electronic systems, secure data handling, audit trails | Mandates calibrated equipment, electronic records and user access controls. |
| USP <1079> | Guidelines for shipping temperature sensitive products | Supports best practices for packaging, suivi et documentation. |
| IATA/WHO | Standards for transporting vaccines and dry ice | Ensures safe air transport and global consistency. |
Conseils pratiques pour les utilisateurs
Review upcoming DSCSA deadlines and assess whether your systems meet interoperability requirements.
Map your global operations to identify which regional guidelines apply; adapt processes accordingly.
Create a compliance checklist covering calibration, surveillance, documentation et formation.
Partner with vendors who provide validated equipment and can supply documentation for audits.
Exemple du monde réel: A U.S. wholesale distributor modernized its warehouse management system to meet DSCSA requirements. By August 2025 it had integrated serialisation, digital documentation and secure user access, avoiding shipment delays and regulatory penalties.
What Technologies Are Transforming Cold Chain Storage in 2025?
A new generation of digital tools and hardware is enhancing visibility, control and efficiency across the cold chain.
IoT Enabled Sensors and Real Time Monitoring
IoT devices—such as smart tapes, sensors and GPS trackers—collect data on temperature, humidité et localisation en temps réel. When sensors detect unsafe temperatures, they automatically send alerts via text or email, permettant une action corrective rapide. IoT sensors with GPS also enable end to end visibility for stakeholders. Predictive analytics can reduce unplanned equipment downtime by jusqu'à 50 % and lower repair costs by 10–20 %.
Intelligence artificielle (IA) and Predictive Analytics
AI algorithms analyse historical and real time data to optimise shipping routes, prévoir la demande et prévoir les pannes d’équipement. AI powered route optimisation considers traffic and weather conditions, reducing transit time and quality degradation. Predictive analytics can also identify upcoming temperature excursions and trigger alerts. Studies indicate that AI can improve decision making and reduce costs across the cold chain.
Blockchain for End to End Traceability
Blockchain creates a tamper proof ledger linking every transaction chronologically. Pour les chaînes d'approvisionnement pharmaceutiques, blockchain ensures data integrity, prevents manipulation et enhances compliance. Real time temperature logs, shipment times and custody data can be shared securely among stakeholders. This transparency builds trust and simplifies audits.
Solar Powered and Sustainable Cold Storage
Unreliable power grids in rural areas and rising energy costs have spurred unités de stockage frigorifiques à énergie solaire. Solar installations reduce total energy costs; utility rates average 13.10 centimes par kWh while commercial solar can cost 3.2–15,5 centimes par kWh. Solar solutions support remote clinics and advance sustainability goals. Entre-temps, emballage durable—including recyclable insulated containers and biodegradable wraps—reduces environmental impact and meets consumer expectations.
Automatisation et robotique
Les installations de stockage frigorifique adoptent des systèmes automatisés de stockage et de récupération (AS/RS) and robotic handling to address labour shortages and increase efficiency. Robots minimise human error and operate without breaks, improving throughput. Automation also provides consistent temperature control and inventory accuracy. According to industry estimates, à propos 80 % of warehouses remain unautomated, highlighting room for growth.
Portable Cryogenic Freezers and Modular Ultra Cold Storage
Advanced therapies often require ultra cold temperatures as low as –80 °C à –150 °C. Portable cryogenic freezers maintain these temperatures even in challenging environments and provide real time tracking and warning notifications. Modular ultra cold units allow facilities to scale capacity quickly, while multi temperature zones accommodate 2–8 °C, –20 °C and –80 °C products.
Résumé des innovations
| Technologie | Avantages clés | Ce que cela signifie pour vous |
| IoT sensors and GPS | Real time temperature and location data, automated alerts | Prevents excursions, optimises routes and enhances visibility. |
| AI route optimisation | Demande de prévisions, identifies optimal paths | Reduces transit time and preserves product quality. |
| Chaîne de blocs | Tamper proof records, secure data sharing | Simplifies audits and strengthens compliance. |
| Stockage à énergie solaire | Lower energy costs, remote operation | Enables sustainable cold chain in off grid areas. |
| Automation/Robotics | Continuous operation, moins d'erreurs | Improves warehouse efficiency and labour utilisation. |
| Congélateurs cryogéniques portables | Ultra cold storage and mobility | Supports gene and cell therapies in diverse locations. |
Conseils pratiques pour les utilisateurs
Implémenter des capteurs IoT on every shipment to monitor temperature and location.
Use AI enabled route planning to adjust deliveries based on real time traffic and weather.
Adopt blockchain based logs for high value or highly regulated products.
Evaluate solar options if your facility faces unreliable power or high energy costs.
Plan for automation to cope with labour shortages and ensure consistency.
Exemple du monde réel: A Southeast Asian logistics provider deployed blockchain and IoT sensors to monitor vaccine shipments. By sharing real time temperature and humidity logs with all stakeholders, the system eliminated data manipulation and improved regulatory compliance.
How to Choose Packaging and Equipment for Cold Chain Storage
Effective cold chain management requires more than refrigerators. Packaging and equipment must preserve product integrity during manufacturing, storage and transport.
Options d'emballage
Insulated containers and liners: Boîtes isolées, pallet shippers and reusable crate liners account for about 40 % of the cold chain packaging market. They maintain temperature stability during transport and storage and can be reused to reduce costs.
Expéditeurs de palettes: Holding roughly 25 % du marché, they are designed for large-volume shipments and can keep products at specific temperatures for days.
Matériaux à changement de phase (PCMS): PCMs and gel packs provide precise temperature control by absorbing or releasing latent heat within defined ranges. Custom PCM packs are available for frozen (–20 ° C), réfrigéré (+5 °C) et ambiant (+22 °C) stabilité.
Panneaux d'isolation sous vide (Vips): VIPs offer superior insulation and thermal stability and can be custom shaped.
Cryovac vacuum-sealed packaging: Removes air and offers leak resistant protection while reducing plastic use.
Smart packaging platforms: Integrate AI and IoT to recommend appropriate packaging and track temperature in real time.
Réutilisable vs. Single Use Packaging
Reusable systems reduce total cost of ownership and environmental impact; the market for reusable temperature controlled packaging reached US $2.5 milliards en 2024 and is expected to double by 2033. Single use options may be necessary for regulatory reasons or when return logistics are impractical. Lors du choix de l'emballage, consider route duration, seasonal temperatures and sustainability goals.
Equipment Considerations
Medical-grade refrigerators and freezers: Provide uniform temperature and microprocessor controls with alarms. Avoid dormitory-style units which can freeze vaccines.
Congélateurs ultra bas: Required for biologics and gene therapies needing –80 °C to –150 °C storage. Units should have redundancy and backup power.
IoT-enabled shippers and data loggers: Provide continuous temperature and location data; calibrer régulièrement.
Backup generators and redundant power: Ensure temperature stability during outages.
Packaging Selection Table
| Solution | Temperature range supported | Use cases | Avantages |
| Conteneurs isolés (PPE, VIP) | 2–8 ° C; –20 ° C; –80 °C (with appropriate refrigerants) | Expéditions de vaccins, biologique, insuline | Léger, réutilisable, custom sizes; maintain temperature for 96 h or more. |
| Expéditeurs de palettes | 2–8 ° C; –20 ° C; cryogenic with dry ice | Large-volume distribution, international transport | Temps de maintien longs, durable; can integrate smart sensors. |
| PCM et packs de gel | Gammes spécifiques (–20 ° C, +5 °C, +22 °C) | Envois mixtes, essais cliniques | Contrôle précis de la température, réutilisable; safe for dry ice restrictions. |
| Cryogenic freezers and LN2 vapour shippers | –80 °C to –190 °C | Cell and gene therapy, tissue engineering | Maintain viability of living cells; require specialized handling. |
| Emballage intelligent | All ranges; dynamic | High value biologics, livraisons à distance | Data integration, route optimisation; reduces packaging errors. |
Conseils pratiques pour les utilisateurs
Conduct thermal validation of packaging for specific routes and conditions.
Pre-condition refrigerants (packs de gel, PCM) to the correct temperature before packing.
Avoid mid-route repacking; each opening introduces risk.
Use data loggers and GPS trackers to document temperature throughout transit.
Envisagez des systèmes réutilisables for regular routes to reduce costs and waste.
Exemple du monde réel: A biotech firm shipping a gene therapy used cryogenic LN2 vapour shippers with IoT sensors. These containers maintained –150 °C conditions for over 120 hours and provided real time data, enabling proactive interventions and avoiding product loss.
Best Practices for Implementing a Compliant Cold Chain System
A robust cold chain extends beyond equipment. It relies on processes, people and risk management.
Core Components Across the Cold Chain
| Scène | Key activities | Plage de températures typique | Implications pratiques |
| Fabrication | Maintain specified temperatures for raw materials and finished products. Determine optimal storage ranges for each step and document them for tech transfer. | 2–8 ° C for most biologics; –20 °C ou moins pour thérapies géniques. | Ensures ingredients remain stable; prevents product degradation before packaging. |
| Stockage | Use refrigerators, cold rooms and warehouses with continuous monitoring and alarms to alert deviations. | 2–8 ° C (réfrigéré) or lower for ultra cold products. | Protects inventory; temperature logs support audits and recalls. |
| Transport | Employ refrigerated vehicles and insulated packaging; data loggers track conditions in transit. | Généralement 2–8 ° C; dry ice or liquid nitrogen for cryogenic transport. | Minimises risk during delivery; documents chain of custody. |
| Distribution | Wholesalers and pharmacies use controlled facilities until dispensing. | Same as storage. | Ensures final product quality and prevents waste. |
Best Practice Checklist
Valider l'équipement: Confirm that refrigerators, freezers and data loggers meet GMP/GDP standards and calibrate them regularly.
Mettre en œuvre une surveillance continue: Use IoT devices and alarm systems to track temperature and humidity in real time.
Maintain robust documentation: Record temperature data, calibration certificates and handling procedures; consider blockchain for tamper proof records.
Former le personnel: Provide comprehensive training on GDP requirements, equipment operation and emergency response. Encourage staff to report issues promptly.
Élaborer des plans d’urgence: Prepare backup power sources, alternative routes and protocols for transferring products to secondary storage.
Conduct risk assessments: Identify potential failures (pannes de courant, vehicle breakdowns, extreme weather) and mitigate them with redundancy and predictive tools.
Auditer régulièrement: Periodic audits verify compliance and uncover gaps. Include external partners in your audit schedule.
Self Assessment Tool (Interactive Idea)
To engage readers, consider adding a simple Cold Chain Readiness Quiz on your website. Ask questions like:
Do you know the correct storage temperature for each of your products?
Are your refrigerators and freezers calibrated and validated within the last year?
Do you use real time monitoring with alerts?
Do you have documented SOPs for packing and handling?
Is there a contingency plan for power failures or transit delays?
A score at the end can direct users to resources or services to address their gaps.
Exemple pratique: A regional pharmacy chain implemented a quarterly self assessment based on GDP guidelines. Scores highlighted weak areas in staff training and documentation, leading to targeted improvements and a 30 % reduction in temperature excursions over six months.
2025 Trends and Market Outlook for Pharmaceutical Cold Chain Storage
Présentation des tendances
The pharmaceutical cold chain is expanding rapidly due to new therapies, rising consumer expectations and sustainability mandates. Les principales tendances comprennent:
Automatisation et robotique: Cold storage facilities increasingly deploy robotics to compensate for labour shortages and improve consistency.
Durabilité: Réfrigération économe en énergie, renewable energy and recyclable packaging are becoming industry standards.
Visibilité de bout en bout: Wider adoption of advanced tracking systems provides real time location and temperature data.
Infrastructure modernisation: Upgrades in insulation, refrigeration systems and on site renewable power are essential to meet efficiency and compliance demands.
IA et analyse prédictive: L'IA optimise les itinéraires, prévoit la demande et prédit les pannes d’équipement.
Growth in the pharmaceutical sector: Demand for temperature sensitive drugs and biologics drives expansion.
Partenariats stratégiques et intégration: Collaboration across manufacturers, packaging suppliers and logistics providers improves resilience.
Derniers progrès réalisés
Rise of biologics and advanced therapies: Sur 40 % de médicaments nouvellement approuvés 2024 étaient des produits biologiques, many requiring cold or ultra cold storage. The cell and gene therapy market is expected to reach NOUS $74.03 milliards 2034, necessitating cryogenic logistics.
Refrigerated storage growth: Demand for 2–8 °C storage is forecasted to grow faster than other temperature segments; biologique (6 % TCAC) et vaccins (5 % TCAC) are driving this surge. Obesity medications are expected to triple in volume by 2030.
Cold storage market expansion: The global cold storage market (covering food and pharmaceuticals) devrait croître de NOUS $35.7 milliards en 2025 pour nous $72 milliards 2033. Key drivers include advanced temperature monitoring, energy efficient designs and rising pharmaceutical distribution needs.
Modernisation of warehouses: Environ 80 % of warehouses remain unautomated, providing significant potential for robotics and automation.
High market growth for cold chain logistics: The global cold chain logistics market is predicted to grow from NOUS $324.85 milliards en 2024 pour nous $862.33 milliards 2032 due to demand for biologics and stricter regulations.
Insistance au marché
As therapies become more sophisticated, temperature controlled logistics is now a strategic asset. Biologics and personalized medicines are highly sensitive to temperature variations and frequently require refrigerated storage. Vaccines—both seasonal and emergent—continue to rely on cold chains, with most finished products needing 2–8 °C storage. Rare disease treatments and specialty drugs often fall within the same range. The global rise in obesity and the popularity of GLP 1 receptor agonists are fueling explosive growth in refrigerated drug volumes.
Environmental and ESG pressures are pushing companies to adopt energy efficient refrigeration technologies, renewable energy sources and emballage biodégradable. Governments and investors are scrutinizing carbon footprints, faire de la durabilité une nécessité concurrentielle. Strategic partnerships and data standardization are enabling better integration across supply chains—by 2025, 74 % des données logistiques devraient être standardisées, improving visibility and resilience.
Questions fréquemment posées
Q1: What does pharmaceutical cold chain storage mean?
Cold chain storage refers to the system of controlling temperature during the manufacturing, stockage, transportation and distribution of temperature sensitive medicines. Il garantit des produits comme les vaccins, biologics and gene therapies stay within specific ranges (Par exemple, 2–8 °C ou –20 °C) to maintain potency and safety.
Q2: How are temperature ranges categorized in the cold chain?
The Healthcare Distribution Alliance classifies four ranges: réfrigéré (2–8 ° C) for insulin and many vaccines; congelé (–20 to –40 °C) for DNA and mRNA vaccines; ultralow (–45 to –93 °C) for certain vaccines; et cryogénique (–150 to –190 °C) pour thérapies cellulaires et géniques. Knowing these categories helps select suitable equipment and packaging.
Q3: What happens if temperature excursions occur?
Temperature excursions—when products fall outside recommended ranges—are the leading cause of product loss. Jusqu'à 80 % of pharmaceutical losses are attributed to temperature excursions. Excursions can degrade drug potency, trigger costly recalls and compromise patient safety. Implement continuous monitoring and contingency plans to mitigate risks.
Q4: How can pharmacies ensure compliance with GDP guidelines?
Pharmacies should implement validated equipment, continuous monitoring with real time alerts, robust documentation and regular staff training. They must maintain products within 2–8 °C or other specified ranges, conduct risk assessments and develop contingency plans for power outages or transit delays.
Q5: What new technologies are emerging in 2025 for cold chain storage?
Key innovations include IoT enabled sensors for real time monitoring, Optimisation des itinéraires basée sur l'IA, blockchain for tamper proof recordkeeping, solar powered cold storage and automation/robotics to streamline cold storage operations.
Q6: Why is sustainability important in pharmaceutical cold chains?
Cold storage facilities account for a significant portion of energy consumption and carbon emissions. Sustainable practices—such as using renewable energy, energy efficient refrigeration systems and recyclable packaging—reduce environmental impact and help companies meet regulatory and consumer expectations. Solar powered units can also lower operational costs.
Q7: How will the cold chain evolve over the next decade?
The next ten years will see rapid growth in 2–8 °C storage, automation and real time visibility. Biologics are projected to grow 6 % TCAC à travers 2035, vaccins 5 %, and obesity medications will triple by 2030. Ultra cold logistics will expand to support cell and gene therapies, while sustainable and modular solutions will become standard.
Résumé et recommandations
Reliable pharmaceutical cold chain storage protects patient safety, supports regulatory compliance and prevents costly product losses. Les principaux points à retenir comprennent:
Maintain strict temperature control: Know the correct range for each product and use validated equipment and calibrated sensors.
Se conformer à la réglementation: Follow GDP/GMP guidelines and prepare for DSCSA traceability requirements by August 27 2025.
Tirer parti de la technologie: Adoptez les capteurs IoT, AI route optimisation, blockchain logs and energy efficient solutions to enhance visibility and reduce risk.
Choisissez le bon emballage: Select insulated containers, PCMs or cryogenic solutions based on temperature requirements and route duration.
Invest in training and contingency planning: Educate staff on handling protocols and prepare for emergencies.
Étapes suivantes (Appel à l'action)
Assess your cold chain readiness: Use a self assessment quiz to identify gaps in equipment, surveillance, documentation et formation.
Upgrade your monitoring infrastructure: Implement IoT and AI tools to gain real time visibility and predictive insights.
Engagez-vous avec des experts: Consult supply chain specialists to validate packaging and logistics strategies.
Planifier la conformité: Create a DSCSA compliance roadmap covering electronic traceability, serialisation and user access controls.
Prioriser la durabilité: Explore solar powered storage, recyclable packaging and energy efficient refrigeration to reduce costs and environmental impact.
À propos du tempk
Rotation is a leading provider of cold chain packaging and temperature control solutions. Nous concevons et fabriquons des caisses isothermes, couvertures de palettes, gel packs and reusable packaging tailored for pharmaceutical shipments. Notre multi temperature product lines support 0–10 °C, 10 °C et moins, and ultra cold ranges to meet diverse logistics needs. With an in house R&D centre and stringent quality control, we deliver validated systems that help customers comply with GDP/GMP requirements and reduce waste. Notre eco friendly product portfolio emphasises reusability and recyclable materials, soutenir les objectifs de développement durable.
What We Offer
Customised cold chain packaging: From gel packs and insulated bags to vacuum insulated panels and electric cooler bags, we offer solutions for every temperature range and shipment duration.
Regulatory support: Our products come with validation data and compliance documentation to simplify audits.
Innovation: We invest in advanced materials and digital monitoring to help clients stay ahead of evolving regulations and technologies.
Prêt à renforcer votre chaîne du froid? Contact Tempk for tailored packaging solutions and expert guidance on building a resilient, sustainable cold chain system.
